Company / Net Income
Integra Lifesciences Holdings Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$516.5M
FY2025
5-year range
-$516.5M / $180.6M
FY2021-FY2025
Trend
-7337.7%
vs FY2024
Sector context
#155 of 164
Health Care
What the data says
Net Income changed -7338% YoY in FY2025, a notable deviation from the 9-year average annual change of -623%.
Based on SEC 10-K filings.
-$516M in FY2025.
Declined from $68M to -$516M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 164This company -$516.5M Sector average $467.5M
▼
-210.5% below sector average
Key checks
Key Insights
- Integra Lifesciences Holdings's net income has declined for 3 consecutive years.
- In FY2025, net income decreased 7337.7% year-over-year.
- Ranks #155 out of 164 companies in the Health Care sector.
- Peak net income was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$516.5M | -7337.7% |
| FY2024 | -$6.9M | -110.3% |
| FY2023 | $67.7M | -62.5% |
| FY2022 | $180.6M | +6.8% |
| FY2021 | $169.1M | +26.3% |
| FY2020 | $133.9M | +166.7% |
| FY2019 | $50.2M | -17.4% |
| FY2018 | $60.8M | +1827.8% |
| FY2017 | -$3.5M | -110.3% |
| FY2016 | $34.0M | +1066.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026